logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Enterocolitis

    FiltersReset Filters
    10 results

    • vancocin

      (vancomycin hydrochloride)
      ANI Pharmaceuticals, Inc.
      Usage: VANCOCIN is indicated for treating Clostridioides difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including MRSA) in patients under 18. It must be administered orally for these infections, as parenteral use is ineffective. It's reserved for proven or suspected bacterial infections to prevent resistance.

    • vancomycin hydrochloride

      (vancomycin hydrochloride)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Vancomycin hydrochloride capsules are indicated for treating Clostridioides difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) in patients under 18 years. They are effective only when administered orally and are not suitable for other infection types.

    • vancomycin hydrochloride

      (vancomycin hydrochloride)
      ANI Pharmaceuticals, Inc.
      Usage: Vancomycin Hydrochloride Capsules are indicated for treating Clostridioides difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including MRSA) in patients under 18. Oral administration is required for these infections; parenteral use is ineffective. They should be used selectively to prevent antibiotic resistance.

    • vancomycin hydrochloride

      (VANCOMYCIN HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: Vancomycin Hydrochloride for Injection is indicated for serious infections caused by methicillin-resistant staphylococci and other susceptible organisms, particularly in penicillin-allergic patients or when other treatments fail. It is effective for conditions like staphylococcal endocarditis, septicemia, and skin infections, among others.

    • vancomycin hydrochloride

      (Vancomycin Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Vancomycin Hydrochloride for Injection is indicated for treating severe infections caused by methicillin-resistant staphylococci, especially in penicillin-allergic patients or those unresponsive to other antibiotics. It is effective for staphylococcal endocarditis, septicemia, and various other infections, but should be used based on susceptibility data.

    • vancomycin hydrochloride

      (Vancomycin Hydrochloride)
      Fresenius Kabi, LLC
      Usage: Vancomycin Hydrochloride for Injection is indicated for serious infections caused by methicillin-resistant staphylococci, especially in penicillin-allergic patients, or when other treatments fail. It's effective for staphylococcal endocarditis and various infections but should be used judiciously to reduce drug resistance. It may also treat antibiotic-associated colitis.

    • vancomycin hydrochloride

      (Vancomycin Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Vancomycin Hydrochloride for Injection is indicated for serious infections caused by methicillin-resistant staphylococci, particularly in penicillin-allergic patients or those unresponsive to other antibiotics. It is effective for staphylococcal endocarditis and other staphylococcal infections, and may be used orally for antibiotic-associated pseudomembranous colitis.

    • vancomycin hydrochloride

      (VANCOMYCIN HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Vancomycin hydrochloride for injection is indicated for serious infections caused by methicillin-resistant staphylococci, particularly in penicillin-allergic patients or those unresponsive to other drugs. It treats endocarditis, septicemia, bone, and skin infections, and can be used orally for antibiotic-associated pseudomembranous colitis and staphylococcal enterocolitis.

    • vancomycin hydrochloride

      (Vancomycin Hydrochloride)
      ANI Pharmaceuticals Inc
      Usage: Vancomycin Hydrochloride for Oral Solution is indicated for the treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic-associated pseudomembranous colitis due to C. difficile. It must be administered orally for these conditions, as parenteral use is ineffective.

    • vancomycin hydrochloride for oral solution

      (vancomycin hydrochloride)
      Wilshire Pharmaceuticals, Inc.
      Usage: Vancomycin hydrochloride is indicated for treating Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including MRSA) in adults and pediatric patients under 18. It must be administered orally for these conditions and is ineffective for other infections when given parenterally.